FIRST CITIZENS BANK & TRUST CO - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST CITIZENS BANK & TRUST CO ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$299,000
+30.6%
2,694
+39.8%
0.01%
+16.7%
Q4 2020$229,000
+6.0%
1,927
+12.6%
0.01%0.0%
Q4 2019$216,0000.0%1,7110.0%0.01%
-53.8%
Q3 2019$216,000
-43.3%
1,711
-46.0%
0.03%
-38.1%
Q2 2019$381,000
+38.0%
3,170
+0.3%
0.04%
+35.5%
Q1 2019$276,000
+20.0%
3,160
+37.7%
0.03%
+10.7%
Q4 2018$230,0002,2950.03%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders